Patent Assignment
Reel/Frame 041694/0288
Change Assignee Address and Correspondence Address
Recorded: 2017-02-13
Pages: 3
Assignor
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Executed: 2007-03-06
Assignee
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
4000 CENTREGREEN WAY, SUITE 300, CARY, NORTH CAROLINA, 27513
Covered Property
(1)
Levothyroxine Compositions and Methods
Patent:
6,555,581 →
Application:
10/077,677 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name
Mar 6, 2007
From: JONES PHARMA INCORPORATED
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC
Reel/Frame 018961/0829 →
Security Agreement
Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest
May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
Security Agreement
May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
Release of Security Interest
Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →